Nx2me vs Modernize 1
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Nx2me
This app assists dialysis patients and their care partners in managing hemodialysis treatments. It collects data from a cycler, allows manual input of vitals and medications, and transmits treatment information to the dialysis center. It also offers troubleshooting guides and virtual support sessions.
- Collects cycler treatment data
- Manual input for vitals and medications
- Transmits treatment flowsheets to dialysis center
- Troubleshooting for alarms and cautions
- Facilitates virtual support sessions
Read full descriptionHide full description
Important: Nx2me® app is intended for use by dialysis patients and care partners while performing hemodialysis treatments with a NxStage cycler and a variety of optional accessory devices, such as blood pressure monitor, weight scale, and thermometer. In order to use this Nx2me app your dialysis center must have signed up for NxStage Medical's Nx2me Connected Health program. The Nx2me app collects treatment information from the Cycler. It is also used by the patient or care partner to enter additional treatment information such as the patient's weight and vitals, medications administered, notes, and patient assessments. This combined information is sent to the patient’s dialysis center as a flowsheet after the treatment is complete. In addition to storing and transmitting flowsheets, the app provides troubleshooting steps for alarms and cautions, and facilitates virtual sessions with NxStage technical support. Dialysis center staff can access the transmitted data using the Nx2me Clinician Portal, gaining enhanced capabilities to review treatment information and support you while at home.
Modernize 1
Read full descriptionHide full description
This app is intended for use by participants in the Modernize 1 study and requires an invitation and activation code from the study site to register. A Phase 2b, Randomized, Multicenter, Double-Blind, Dose-Finding, Active-Controlled Study of Siplizumab (TCD601) Compared to Rabbit Anti-Thymocyte Globulin in Renal Transplant Recipients Requiring Induction Therapy and Receiving Standard of Care Immunosuppression with Tacrolimus, Mycophenolic Acid and Corticosteroids (MODERNIZE 1). This study has been reviewed and approved by the appropriate regulatory body, e.g. Institutional Review Board (IRB) or Independent Ethics Committee (IEC). Key App Features: - Patient Onboarding – complete study app registration and education - Activities – complete scheduled or on-demand study tasks and assessments - Dashboard – review overall progress in the study and current activities - Resources – view study information in the Learn section of the app - Profile – manage account details and app settings - Notifications – receive in-app reminders - Telehealth – conduct scheduled virtual visits with your study site About THREAD: THREAD’s® purpose is to leverage its clinical research platform to enable studies for everyone, everywhere. The company’s uniquely combined clinical research technology and consulting services help life science organizations to design, operate, and scale next-generation research studies and electronic clinical outcome assessments (eCOA) programs for participants, sites, and study teams. Through its comprehensive platform and scientific expertise, THREAD empowers studies to be accessible, efficient, and centered on the patient.
Screenshots
Verdict
The clearest difference is device support: Modernize 1 at 3 against Nx2me's 1. On price, ads, in-app purchases and iOS requirement there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
| Parameter | Nx2me | Modernize 1 |
|---|---|---|
| Price | Free | Free |
| Rating | 3.5 (10 ratings) — better | — |
| Positive reviews | 0.0% of reviews | — |
| Number of ratings | 10 — better | — |
| Update frequency | Every 8 months | — |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPad | iPhone, iPad, iPod — better |
| Requires iOS | 15.0 — better | 15.5 |
| Further details — not scored | ||
| Size | 34 MB | 69 MB |
| Age rating | 12+ | 17+ |
| Developer | NxStage Medical, Inc. | Hello Thread |
In-app purchases
Nx2me
No in-app purchases
Modernize 1
No in-app purchases







